Related references
Note: Only part of the references are listed.HIPK2 in the physiology of nervous system and its implications in neurological disorders
F. Sardina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2023)
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
Alessia Garufi et al.
CANCERS (2023)
HIPK2 as a Novel Regulator of Fibrosis
Alessia Garufi et al.
CANCERS (2023)
MiR-221-3p targets HIPK2 to promote diabetic wound healing
Qiqi Yu et al.
MICROVASCULAR RESEARCH (2022)
The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study
Alessia Garufi et al.
BIOMOLECULES (2022)
ASH2L Aggravates Fibrosis and Inflammation through HIPK2 in High Glucose-Induced Glomerular Mesangial Cells
Wen Zhong et al.
GENES (2022)
Hyperglycaemia-Linked Diabetic Foot Complications and Their Management Using Conventional and Alternative Therapies
Prawej Ansari et al.
APPLIED SCIENCES-BASEL (2022)
TRAF2 regulates the protein stability of HIPK2
Impyo Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
Andrea Panunzi et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets?
Simona Cataldi et al.
ANTIOXIDANTS (2022)
Type 2 Diabetes, Obesity, and Cancer Share Some Common and Critical Pathways
Ishrat Rahman et al.
FRONTIERS IN ONCOLOGY (2021)
MiR-423-5p activated by E2F1 promotes neovascularization in diabetic retinopathy by targeting HIPK2
Qing Xiao et al.
DIABETOLOGY & METABOLIC SYNDROME (2021)
Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
Wei Zhu et al.
FRONTIERS IN ONCOLOGY (2021)
Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2
Dong Ha Kim et al.
CELL DEATH & DISEASE (2021)
The nutrient sensor OGT regulates Hipk stability and tumorigenic-like activities in Drosophila
Kenneth Kin Lam Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
miRNA-221-3p in Endothelial Progenitor Cell-Derived Exosomes Accelerates Skin Wound Healing in Diabetic Mice
Juan Xu et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Chromatin Targeting of HIPK2 Leads to Acetylation-Dependent Chromatin Decondensation
Jana Haas et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2
Hui-Ying Hu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials
Xinhui Wang et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Mara Cirone et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Effects of hyperglycemia on the progression of tumor diseases
Wenjie Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Understanding the multifaceted mechanisms of diabetic wound healing and therapeutic application of stem cells conditioned medium in the healing process
Lai Woon Fui et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)
NFE2/miR-423-5p/TFF1 axis regulates high glucose-induced apoptosis in retinal pigment epithelial cells
Qing Xiao et al.
BMC MOLECULAR AND CELL BIOLOGY (2019)
Diabetic Retinopathy: Pathophysiology and Treatments
Wei Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis (Publication with Expression of Concern. See vol. 129, pg. 1803, 2019)
Celine Hernandez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Highlighting Diabetes Mellitus: The Epidemic Continues
Ann Marie Schmidt
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
Pengzi Zhang et al.
ANNALS OF MEDICINE (2017)
Hyperglycemia triggers HIPK2 protein degradation
Silvia Baldari et al.
ONCOTARGET (2017)
p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
Alessia Garufi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression
Xiaoyan Chang et al.
KIDNEY INTERNATIONAL (2017)
Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses
L. Torrente et al.
ONCOGENE (2017)
Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies
Yuanyuan Feng et al.
ONCOTARGET (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia
Rachel K. Toth et al.
ANTIOXIDANTS (2017)
Impact of hyperglycemia on the efficacy of chemotherapy-A systematic review of preclinical studies
Maaike C. Gerards et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Heat shock modulates the subcellular localization, stability, and activity of HIPK2
Mamta Upadhyay et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Zinc supplementation alleviates hyperglycemia and associated metabolic abnormalities in streptozotocin-induced diabetic rats
Susmita Barman et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
O-GIcNAcylation in Cancer Biology: Linking Metabolism and Signaling
Christina M. Ferrer et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose
A. Garufi et al.
CELL DEATH & DISEASE (2016)
Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy
Hyung Jung Oh et al.
SCIENTIFIC REPORTS (2016)
High Glucose Promotes Tumor Invasion and Increases Metastasis-Associated Protein Expression in Human Lung Epithelial Cells by Upregulating Heme Oxygenase-1 via Reactive Oxygen Species or the TGF-beta(1)/PI3K/Akt Signaling Pathway
Xiaowen Kang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity
Davide Valente et al.
ONCOTARGET (2015)
Diabetic kidney disease
Merlin C. Thomas et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation
Michal Sheffer et al.
Oncotarget (2015)
Integration of stress signals by homeodomain interacting protein kinases
Michael Lienhard Schmitz et al.
BIOLOGICAL CHEMISTRY (2014)
Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization
Tilman Polonio-Vallon et al.
CELL CYCLE (2014)
High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
Alessia Garufi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Hyperglycemia as a Risk Factor for Cancer Progression
Tae Young Ryu et al.
DIABETES & METABOLISM JOURNAL (2014)
HIPK2 modification code for cell death and survival
Dong Wook Choi et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis
Thomas G. Hofmann et al.
BIOESSAYS (2013)
DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control
Xi Chen et al.
BMC BIOLOGY (2013)
Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis
Alberto Ricci et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Posttranslational modifications regulate HIPK2, a driver of proliferative diseases
Vera V. Saul et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Hyperglycemia of Tumor Microenvironment Modulates Stage-Dependent Tumor Progression and Multidrug Resistance: Implication of Cell Survival Regulatory Molecules and Altered Glucose Transport
Naveen Kumar Vishvakarma et al.
MOLECULAR CARCINOGENESIS (2013)
Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells
Mara Cirone et al.
ONCOIMMUNOLOGY (2013)
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion
Cristina Nodale et al.
CANCER BIOLOGY & THERAPY (2012)
Homeodomain-Interacting Protein Kinase Regulates Yorkie Activity to Promote Tissue Growth
Joanna Chen et al.
CURRENT BIOLOGY (2012)
A Redox-Regulated SUMO/Acetylation Switch of HIPK2 Controls the Survival Threshold to Oxidative Stress
Laureano de la Vega et al.
MOLECULAR CELL (2012)
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis
Yuanmeng Jin et al.
NATURE MEDICINE (2012)
Control of nuclear HIPK2 localization and function by a SUMO interaction motif
Laureano de la Vega et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage
C. Lazzari et al.
ONCOGENE (2011)
Cutaneous HPV23 E6 Prevents p53 Phosphorylation through Interaction with HIPK2
Dorothea Muschik et al.
PLOS ONE (2011)
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
Serena Stanga et al.
AGING-US (2010)
Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization
Rong An et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
HIPK2-A therapeutical target to be (re)activated for tumor suppression Role in p53 activation and HIF-1α inhibition
Lavinia Nardinocchi et al.
CELL CYCLE (2010)
Glucose Regulates Steady-state Levels of PDX1 via the Reciprocal Actions of GSK3 and AKT Kinases
Rohan K. Humphrey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein
Tsubasa Isoe et al.
KIDNEY INTERNATIONAL (2010)
Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells
R. Puca et al.
ONCOGENE (2010)
Zinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo
Lavinia Nardinocchi et al.
PLOS ONE (2010)
Transcriptional regulation of hypoxia-inducible factor 1α by HIPK2 suggests a novel mechanism to restrain tumor growth
Lavinia Nardinocchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1
Se-Yong Kim et al.
CANCER LETTERS (2009)
Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression
Giulia Bon et al.
CANCER RESEARCH (2009)
HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage
S. Iacovelli et al.
CELL PROLIFERATION (2009)
The Homeodomain-Interacting Protein Kinase 2 Regulates Insulin Promoter Factor-1/Pancreatic Duodenal Homeobox-1 Transcriptional Activity
Marie-Josee Boucher et al.
ENDOCRINOLOGY (2009)
PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53
Jun Mi et al.
MOLECULAR CANCER THERAPEUTICS (2009)
An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response
Marco A. Calzado et al.
NATURE CELL BIOLOGY (2009)
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
Yair Benita et al.
NUCLEIC ACIDS RESEARCH (2009)
Zinc in Cancer Prevention
Ananda S. Prasad et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)
Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α
Lavinia Nardinocchi et al.
PLOS ONE (2009)
Obesity-induced insulin resistance and hyperglycemia - Etiologic factors and molecular mechanisms
J. A. Jeevendra Martyn et al.
ANESTHESIOLOGY (2008)
Expression of HIPK2 in cervical cancer: Correlation with clinicopathology and prognosis
Mariam A. M. Al-Beiti et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2008)
PEBP2-β/CBF-β-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis
Hee-Jun Wee et al.
BLOOD (2008)
Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown
Rosa Puca et al.
CANCER RESEARCH (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
PML Activates Transcription by Protecting HIPK2 and p300 from SCFFbx3-Mediated Degradation
Yutaka Shima et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR
Melanie Winter et al.
NATURE CELL BIOLOGY (2008)
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas
H. Deshmukh et al.
ONCOGENE (2008)
Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1
Dong Wook Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1-and p53-mediated transcription
X-L Li et al.
ONCOGENE (2007)
MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis
Cinzia Rinaldo et al.
MOLECULAR CELL (2007)
HIPK2 - a versatile switchboard regulating the transcription machinery and cell death
Marco A. Calzado et al.
CELL CYCLE (2007)
Involvement of α6β4 integrin in the mechanisms that regulate breast cancer progression
Giulia Bon et al.
BREAST CANCER RESEARCH (2007)
Metabolic mechanisms of stress hyperglycemia
Jeffrey I. Mechanick
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2006)
Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells
G D'Orazi et al.
CLINICAL CANCER RESEARCH (2006)
The complexity of p53 stabilization and activation
M. F. Lavin et al.
CELL DEATH AND DIFFERENTIATION (2006)
HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations
V Di Stefana et al.
FEBS LETTERS (2005)
HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function
V Di Stefano et al.
ONCOGENE (2004)
Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP
OH Zhang et al.
CELL (2003)
Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
TG Hofmann et al.
NATURE CELL BIOLOGY (2002)
Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis
G D'Orazi et al.
NATURE CELL BIOLOGY (2002)
Role of promyelocytic leukemia (PML) protein in tumor suppression
EM Rego et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34
TG Hofmann et al.
BIOCHIMIE (2000)
Share Paper
